Ludhiana: The department of vegetable science at Punjab Agricultural University (PAU) has achieved a significant milestone by ...

Analysis of Patients from CLEAR Outcomes Receiving No Other Background Lipid Lowering Therapies, Bempedoic Acid Alone Reduced MACE-4 by 14% ...

Editas Medicine, Inc. (Nasdaq: EDIT), a pioneering gene editing company focused on developing transformative medicines for serious diseases, today announced a moderated digital poster presentation at ...

RAJSHAHI, Nov 14, 2025 (BSS) - A two-day international conference on Recent Advances in Science and Technology began at ...

R&D Day showcased remarkable Investigator optimism, continued strengthening supportive data, and significant progress with Phase 3 OVATION 3 ...

In addition to networking and scientific sessions, conference attendees had the opportunity to appreciate the rich ...

Medifast, the health and wellness company known for its science-backed, coach-guided lifestyle system, continues to lead the charge in addressing the growing health crisis of metabolic dysfunction by ...

HTC-19 in Leuven will showcase the latest advancements in hyphenated techniques. This preview offers a glimpse of what you ...

Taiho Oncology, Inc., a company developing and commercializing novel treatments for hematologic malignancies and solid tumors ...

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced that six abstracts have been accepted for presentation at the Society for ...

An academic foray to Cuba immersed four SUNY Cortland students in music, dance and art as well as scholarship.

MRT-8102 is a selective, potent, and durable NEK7 degrader. Activation of the NLRP3 inflammasome critically depends on NEK7. Administration of MRT-8102 led to inhibition of NLRP3 inflammasome in vitro ...